These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34271235)

  • 1. Emergence of GES-19-producing Pseudomonas aeruginosa exoU+ belonging to the global high-risk clone ST235 in cystic fibrosis infection.
    Rosales-Reyes R; Esposito F; Fontana H; Lezana-Fernández JL; Lascurain R; De la Cruz MA; Fuga B; Lincopan N; Santos-Preciado JI
    Diagn Microbiol Infect Dis; 2021 Sep; 101(1):115454. PubMed ID: 34271235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial Resistance and Type III Secretion System Virulotypes of Pseudomonas aeruginosa Isolates from Dogs and Cats in Primary Veterinary Hospitals in Japan: Identification of the International High-Risk Clone Sequence Type 235.
    Hayashi W; Izumi K; Yoshida S; Takizawa S; Sakaguchi K; Iyori K; Minoshima KI; Takano S; Kitagawa M; Nagano Y; Nagano N
    Microbiol Spectr; 2021 Oct; 9(2):e0040821. PubMed ID: 34585944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of VIM-2-producing Pseudomonas aeruginosa isolates from lower tract respiratory infections in a Spanish hospital.
    Bellés A; Bueno J; Rojo-Bezares B; Torres C; Javier Castillo F; Sáenz Y; Seral C
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1847-1856. PubMed ID: 29978304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: Facing the perfect storm.
    Recio R; Villa J; Viedma E; Orellana MÁ; Lora-Tamayo J; Chaves F
    Int J Antimicrob Agents; 2018 Aug; 52(2):172-179. PubMed ID: 29621591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Characterization of Extended-Spectrum Beta Lactamase- and Carbapenemase-Producing Pseudomonas aeruginosa Strains from a Malaysian Tertiary Hospital.
    Phoon HYP; Hussin H; Hussain BM; Thong KL
    Microb Drug Resist; 2018 Oct; 24(8):1108-1116. PubMed ID: 29437541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay among Resistance Profiles, High-Risk Clones, and Virulence in the Caenorhabditis elegans Pseudomonas aeruginosa Infection Model.
    Sánchez-Diener I; Zamorano L; López-Causapé C; Cabot G; Mulet X; Peña C; Del Campo R; Cantón R; Doménech-Sánchez A; Martínez-Martínez L; Arcos SC; Navas A; Oliver A
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local outbreak of extended-spectrum β-lactamase SHV2a-producing Pseudomonas aeruginosa reveals the emergence of a new specific sub-lineage of the international ST235 high-risk clone.
    Royer G; Fourreau F; Boulanger B; Mercier-Darty M; Ducellier D; Cizeau F; Potron A; Podglajen I; Mongardon N; Decousser JW
    J Hosp Infect; 2020 Jan; 104(1):33-39. PubMed ID: 31369808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Characterization of Carbapenemase-Producing Pseudomonas aeruginosa of Czech Origin and Evidence for Clonal Spread of Extensively Resistant Sequence Type 357 Expressing IMP-7 Metallo-β-Lactamase.
    Papagiannitsis CC; Medvecky M; Chudejova K; Skalova A; Rotova V; Spanelova P; Jakubu V; Zemlickova H; Hrabak J;
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28993328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update.
    Del Barrio-Tofiño E; López-Causapé C; Oliver A
    Int J Antimicrob Agents; 2020 Dec; 56(6):106196. PubMed ID: 33045347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unravelling the genome of a Pseudomonas aeruginosa isolate belonging to the high-risk clone ST235 reveals an integrative conjugative element housing a blaGES-6 carbapenemase.
    Botelho J; Grosso F; Peixe L
    J Antimicrob Chemother; 2018 Jan; 73(1):77-83. PubMed ID: 29029083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic characteristics of Pseudomonas aeruginosa bacteraemia isolates in a high-endemicity setting for ST175 and ST235 high-risk clones.
    Recio R; Sánchez-Diener I; Viedma E; Meléndez-Carmona MÁ; Villa J; Orellana MÁ; Mancheño M; Juan C; Zamorano L; Lora-Tamayo J; Chaves F; Oliver A
    Eur J Clin Microbiol Infect Dis; 2020 Apr; 39(4):671-678. PubMed ID: 31823150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nosocomial dissemination of VIM-2-producing ST235 Pseudomonas aeruginosa in Lithuania.
    Mikucionyte G; Zamorano L; Vitkauskiene A; López-Causapé C; Juan C; Mulet X; Oliver A
    Eur J Clin Microbiol Infect Dis; 2016 Feb; 35(2):195-200. PubMed ID: 26638216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal Dissemination of Pseudomonas aeruginosa Sequence Type 235 Isolates Carrying blaIMP-6 and Emergence of blaGES-24 and blaIMP-10 on Novel Genomic Islands PAGI-15 and -16 in South Korea.
    Hong JS; Yoon EJ; Lee H; Jeong SH; Lee K
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7216-7223. PubMed ID: 27671068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First detection of autochthonous extensively drug-resistant NDM-1 Pseudomonas aeruginosa ST235 from a patient with bloodstream infection in Italy, October 2019.
    Loconsole D; Accogli M; Monaco M; Del Grosso M; De Robertis AL; Morea A; Capozzi L; Del Sambro L; Simone A; De Letteriis V; Quarto M; Parisi A; Chironna M
    Antimicrob Resist Infect Control; 2020 May; 9(1):73. PubMed ID: 32450907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An outbreak of fluoroquinolone-resistant Pseudomonas aeruginosa ST357 harboring the exoU gene.
    Kainuma A; Momiyama K; Kimura T; Akiyama K; Inoue K; Naito Y; Kinoshita M; Shimizu M; Kato H; Shime N; Fujita N; Sawa T
    J Infect Chemother; 2018 Aug; 24(8):615-622. PubMed ID: 29628388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital wastewater as source of human pathogenic bacteria: A phenotypic and genomic analysis of international high-risk clone VIM-2-producing Pseudomonas aeruginosa ST235/O11.
    Zagui GS; de Almeida OGG; Moreira NC; Silva NGA; Meschede MSC; Darini ALC; Andrade LN; Segura-Muñoz SI
    Environ Res; 2024 Aug; 255():119166. PubMed ID: 38759772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of
    Arfaoui A; Rojo-Bezares B; Fethi M; López M; Toledano P; Sayem N; Ben Khelifa Melki S; Ouzari HI; Klibi N; Sáenz Y
    J Med Microbiol; 2024 Jul; 73(7):. PubMed ID: 38963417
    [No Abstract]   [Full Text] [Related]  

  • 19. Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.
    Liakopoulos A; Mavroidi A; Katsifas EA; Theodosiou A; Karagouni AD; Miriagou V; Petinaki E
    BMC Infect Dis; 2013 Oct; 13():505. PubMed ID: 24168643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of bla
    Li X; Zhang X; Cai H; Zhu Y; Ji J; Qu T; Tu Y; Zhou H; Yu Y
    Drug Resist Updat; 2023 Jul; 69():100973. PubMed ID: 37148599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.